Role of protective drugs in the prevention of ulcer relapse.

The efficacy of gastric acid suppressive drugs, such as histamine H2-receptor antagonists and H+K+ ATPase inhibitors, in the management of peptic ulcer diseases has been well established. They accelerate the healing of peptic ulcers, and maintenance therapy with these drugs prevents ulcer relapse. However, they do not modulate the natural course of peptic ulcer. Sucralfate, a protective drug, has been shown to be equally effective in ulcer healing and the prevention of ulcer relapse. Some reports suggest that the relapse rate of ulcers treated successfully with sucralfate is less than that seen with histamine H2-receptor antagonists. Sucralfate has a true cytoprotective effect against agents noxious to gastric epithelial cells in monolayer culture. This action might be associated with its therapeutic efficacy in the treatment and prevention of ulcer diseases. The role played by other protective drugs in the management of ulcer diseases is less clear and requires further studies.
AuthorsS Ota, A Terano
JournalJournal of gastroenterology (J Gastroenterol) Vol. 29 Suppl 7 Pg. 139-40 (Jul 1994) ISSN: 0944-1174 [Print] JAPAN
PMID7921147 (Publication Type: Journal Article, Review)
Chemical References
  • Anti-Ulcer Agents
  • Sucralfate
  • Cimetidine
  • Anti-Ulcer Agents (therapeutic use)
  • Cimetidine (therapeutic use)
  • Duodenal Ulcer (drug therapy)
  • Humans
  • Peptic Ulcer (drug therapy, prevention & control)
  • Recurrence
  • Sucralfate (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: